Montana § 33-32-106 Disclosure Of Utilization Review Requirements -- Drug Benefit Information

Montana Statutes

§ 33-32-106 — Disclosure Of Utilization Review Requirements -- Drug Benefit Information

Montana § 33-32-106

Title 33INSURANCE AND INSURANCE COMPANIES

Ch. 32HEALTH UTILIZATION REVIEW

Part 1General Provisions

This text of Montana § 33-32-106 (Disclosure Of Utilization Review Requirements -- Drug Benefit Information) is published on Counsel Stack Legal Research, covering Montana primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

Mont. Code Ann. § 33-32-106 (2026).

Text

33-32-106 . Disclosure of utilization review requirements -- drug benefit information.

(1)A utilization review organization shall make its current utilization review plan prepared pursuant to 33-32-103 , including clinical review criteria, standards, procedures, requirements, and restrictions, readily accessible on its website to covered persons, prospective covered persons, and health care providers. The utilization review plan must be described in detail and in easily understandable language.

(2)If a utilization review organization intends to implement a new or amended utilization review plan, including any new or amended clinical review criteria, standards, procedures, requirements, or restrictions, the entity may not implement the change until it has:

(a)notified health care provide

Free access — add to your briefcase to read the full text and ask questions with AI

33-32-106 . Disclosure of utilization review requirements -- drug benefit information. (1) A utilization review organization shall make its current utilization review plan prepared pursuant to 33-32-103 , including clinical review criteria, standards, procedures, requirements, and restrictions, readily accessible on its website to covered persons, prospective covered persons, and health care providers. The utilization review plan must be described in detail and in easily understandable language.
(2) If a utilization review organization intends to implement a new or amended utilization review plan, including any new or amended clinical review criteria, standards, procedures, requirements, or restrictions, the entity may not implement the change until it has:
(a) notified health care providers in writing of the new or amended utilization review plan, including any new or amended clinical review criteria, standards, procedures, requirements, or restrictions, no less than 60 days before the new or amended plan is to be implemented; and
(b) updated its website to reflect the new or amended utilization review plan, including any new or amended clinical review criteria, standards, procedures, requirements, or restrictions, to make the information accessible to covered persons, prospective covered persons, and health care providers.
(3) A health insurance issuer or utilization review organization, as applicable, shall display on its public website current prescription drug benefit information, including formulary lists of each prescription drug covered under the health insurance issuer's plan.